Literature DB >> 107745

Partial splenic embolization in the treatment of hypersplenism.

D G Spigos, O Jonasson, M Mozes, V Capek.   

Abstract

Transcatheter embolization of the spleen has been associated with serious complications, such as splenic abscess, rupture of the spleen, pneumonia, and septicemia. These complications, with their grave consequences, have prevented the use of this procedure as an alternative to operative splenectomy in selected cases. A detailed description of our method, which consists of partial splenic embolization, antibiotic prophylaxis, adequate pain control, and careful pre- and postembolization, is reported. Thirteen patients with hypersplenism were successfully treated with transcatheter partial embolization of their spleen.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 107745     DOI: 10.2214/ajr.132.5.777

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  64 in total

1.  The role of the spleen, especially regarding changes in both thromboxane A2 and the remnant liver dysfunction after extensive hepatectomy.

Authors:  M Kitagawa; K Tanigawa; M Iwata
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients.

Authors:  Takuya Iwamoto; Shuji Terai; Yuko Mizunaga; Naoki Yamamoto; Kaoru Omori; Koichi Uchida; Takahiro Yamasaki; Yasuhiko Fujii; Hiroshi Nishina; Isao Sakaida
Journal:  J Gastroenterol       Date:  2011-11-09       Impact factor: 7.527

Review 3.  Balloon-occluded retrograde transvenous obliteration for portal hypertension.

Authors:  Shozo Hirota; Kaoru Kobayashi; Hiroaki Maeda; Satoshi Yamamoto; Norio Nakao
Journal:  Radiat Med       Date:  2006-05

4.  Transhepatic catheter-directed thrombolysis for portal vein thrombosis after partial splenic embolization in combination with balloon-occluded retrograde transvenous obliteration of splenorenal shunt.

Authors:  Motoki Nakai; Morio Sato; Shinya Sahara; Nobuyuki Kawai; Masashi Kimura; Yoshimasa Maeda; Yumiko Ibata; Katsuhiko Higashi
Journal:  World J Gastroenterol       Date:  2006-08-21       Impact factor: 5.742

5.  Improved prognosis of cirrhosis patients with esophageal varices and thrombocytopenia treated by endoscopic variceal ligation plus partial splenic embolization.

Authors:  Kenji Ohmoto; Naoko Yoshioka; Yasuyuki Tomiyama; Norikuni Shibata; Michihiko Takesue; Koji Yoshida; Makoto Kuboki; Shinichiro Yamamoto
Journal:  Dig Dis Sci       Date:  2006-02       Impact factor: 3.199

6.  Evaluation of the effect of partial splenic embolization on platelet values for liver cirrhosis patients with thrombocytopenia.

Authors:  Chi-Ming Lee; Ting-Kai Leung; Hung-Jung Wang; Wei-Hsing Lee; Li-Kuo Shen; Jean-Dean Liu; Chun-Chao Chang; Ya-Yen Chen
Journal:  World J Gastroenterol       Date:  2007-01-28       Impact factor: 5.742

7.  Laparoscopic splenic vessels ligation as a treatment of hypersplenism and thrombocytopenia in children.

Authors:  Jin-Shan Zhang; Long Li; Qi Li; Wei Cheng
Journal:  Surg Endosc       Date:  2015-12-10       Impact factor: 4.584

8.  Partial splenic embolization in a child with hereditary spherocytosis.

Authors:  M Jiménez; C Azcona; L Castro; J I Bilbao; P León; L Sierrasesúmaga
Journal:  Eur J Pediatr       Date:  1995-06       Impact factor: 3.183

9.  Splenic embolization.

Authors:  D G Spigos; W S Tan; M F Mozes; K Pringle; I Iossifides
Journal:  Cardiovasc Intervent Radiol       Date:  1980       Impact factor: 2.740

10.  Partial splenic embolization versus splenectomy for the management of hypersplenism in cirrhotic patients.

Authors:  Mahmoud A Amin; Mohamed M el-Gendy; Ibrahim E Dawoud; Ashraf Shoma; Ahmed M Negm; Talal A Amer
Journal:  World J Surg       Date:  2009-08       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.